View daily weekly or. On average they anticipate AbCellera Biologics stock price to reach 5280 in the next year.
Abcellera Biologics Crunchbase Investor Profile Investments
The change will be -10000.
Abcellera stock price. The stock price of AbCellera Nasdaq. 5 Wall Street analysts have issued ratings and price targets for AbCellera Biologics in the last 12 months. View real-time stock prices and stock quotes for a full financial overview.
The Abcellera Biologics Inc PE ratio based on its reported earnings over the past 12 months is 6609The shares are currently trading at 2893. AbCellera 2825 058 210 AbCellera NASDAQ Updated May 11 2021 141 PM. ABCL Complete AbCellera Biologics Inc.
ABCL increased by over 7 during intraday trading this morning. The AbCellera Biologics stock price may drop from 29070 USD to 0000001 USD. Their average twelve-month price target is 5280 predicting that the stock has a possible upside of 8690.
This suggests a possible upside of 547 from the stocks current price. 102 рядків Discover historical prices for ABCL stock on Yahoo Finance. AbCellera Biologics ABCL stock price revenue and financials.
AbCellera announced the pricing of its initial public offering of 24150000 common shares at a price to the public of 2000 per share. Stock news by MarketWatch. Price Price Target Lowest.
VANCOUVER British Columbia--BUSINESS WIRE--AbCellera announced the pricing of its initial public offering of 24150000 common shares at a price to the public of 2000 per share. ABCL stock quote history news and other vital information to help you with your stock trading and investing. Get todays Abcellera Biologics Inc stock price and latest ABCL news as well as Abcellera Biologics real-time stock quotes technical analysis full financials and more.
Get the latest AbCellera Biologics Inc ABCL real-time quote historical performance charts and other financial information to help you make more informed trading and investment decisions. Find the latest AbCellera Biologics Inc. Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS.
Real-time Price Updates for Abcellera Biologics Inc ABCL-Q. ABCL a technology company with a centralized operating system for next-generation antibody discovery increased by over 7 during intraday trading this morning. Will ABCL stock price grow rise go up.
The stock price of The AbCellera Nasdaq. AbCellera Biologics market cap is 83 b and annual revenue was 1161 m in FY 2019. Charting Tear Sheets Press Price Performance more.
This is why it happened. The PE ratio or price-to-earnings ratio is the one of the most popular valuation measures used by stock market investors. Common Shares ABCL Stock Quotes - Nasdaq offers stock quotes market activity data for US and global markets.
5900 The average price target includes all analyst analysis not just the most recent analysis presented in the chart. The high price target for ABCL is 5900 and the low price. 5 brokers have issued twelve-month target prices for AbCellera Biologics stock.
AbCellera Biologics Inc. ABCL AbCellera Stock Price and Discussion Stocktwits. Their forecasts range from 4500 to 5900.
Biotech Company Abcellera Stock Triples In Nasdaq Debut Video Bnn
Abcellera Biologics Inc Ipo Investment Prospectus S 1 A
Pharma Stock Roundup Abbv Lly Coronavirus Product Development Efforts Fda Updates
Abcellera Biologics Inc Stock Info
Ipo Launch Abcellera Biologics Readies 357 Million Ipo Ipos On Thestreet U S Ipo Research Opinion
Abcellera Biologics A Compounding Machine Nasdaq Abcl Seeking Alpha
Abcellera Ipo Rockets Upward With 555 5m In Gross Proceeds 2020 12 28 Bioworld
Vancouver Based Abcellera Goes Public On Nasdaq With Massive Us 555 5m Ipo Company S Market Value Triples To 15 7 Billion On 1st Day T Net News
Abcellera Announces Pricing Of Initial Public Offering Business Wire
Abcellera Biologics Inc Stock Info
Comments
Post a Comment